Tess Egginton

SIGA Technologies' antiviral treatment TEPOXX (tecovirimat 200 mg capsules), marketed as TPOXX in the United States, has received regulatory approval in Japan for the...

Candid Therapeutics, a clinical-stage biotechnology company focused on advancing T-cell engagers for autoimmune and inflammatory diseases, has entered an agreement with WuXi Biologics under...

The China National Medical Products Administration has approved GSK's Nucala (mepolizumab), a monoclonal antibody that targets interleukin-5 (IL-5), as an add-on therapy with intranasal...